The Nanomedicine Technologies Platform is a research and development infrastructure focused on targeted drug delivery systems and nanotechnology-based therapeutic approaches. Within the scope of the platform, research is carried out particularly on the development of nanoparticles capable of delivering smart therapies directly to the target site in cancer treatment, while targeted drug approaches for different diseases are also pursued. The platform is structured to support both research groups within the center and spin-off initiatives emerging from its innovation and entrepreneurship ecosystem.

One of the platform’s most prominent achievements is that one of Türkiye’s first drug candidates to reach the clinical stage was developed within this infrastructure. All non-GLP preclinical studies related to this lead candidate were conducted at the center. In this respect, the platform provides a strong research environment that supports the translation of scientific research into application and plays a pioneering role in the development of innovative nanomedicine solutions at both national and international levels.

For communication and further information, you may contact us via [email protected]